Appetite-stimulating medication for advanced liver cancer with weight loss
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study tests a new form of megestrol acetate (a medication that helps stimulate appetite and weight gain) for people with advanced liver cancer who are experiencing weight loss or loss of appetite. It is given alongside standard treatments for liver cancer, and the goal is to see if it can improve appetite and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have liver cancer that has not spread and cannot be removed with surgery, and you have not had any previous treatment for it.
- Your liver function is good or only slightly reduced (Child-Pugh class A or B7).
- You are planning to have a combination of interventional therapy (like procedures that target the tumor) and systemic therapy (like pills or injections that work throughout the body).
- You have at least one tumor that can be measured on a scan.
- You meet the criteria for weight loss or loss of appetite (pre-cachexia or cachexia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a drug called nanocrystalline megestrol acetate can help improve appetite and weight loss in people with advanced liver cancer. It is given as a pill and is compared against a placebo (a pill with no active medicine).
This study tests a special form of megestrol acetate (a medicine that can help with appetite and weight gain) in people with advanced digestive system cancers who are about to start or are already taking a type of targeted therapy called a TKI. The goal is to see if it helps with cancer-related weight loss and wasting (cachexia).
This trial tests a newer form of megestrol acetate (a medication that can help with appetite and weight) given alongside standard chemotherapy and radiation for locally advanced cervical cancer that cannot be removed by surgery. The study aims to see if this combination is safe and effective.
This study tests whether adding a drug that boosts appetite and weight to standard lung cancer treatment helps people with advanced small cell lung cancer who are experiencing weight loss and poor appetite. It aims to improve quality of life and treatment outcomes.
This trial tests a medicine called megestrol acetate (a type of hormone therapy) given after surgery to see if it helps improve appetite and weight in people with high-risk head and neck cancer. It is given alongside the usual radiation and chemotherapy treatment.
This study tests a special form of the drug megestrol acetate (Megace) in cancer patients who have lost weight and appetite (cachexia). It aims to see if this medication can help improve weight gain and quality of life.
Hear when a new Cachexia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.